- Home
- TLSI vs PDYN Comparison
TLSI vs PDYN Comparison
Compare TLSI & PDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- PDYN
- Stock Information
- Founded
- TLSI 2010
- PDYN 1983
- Country
- TLSI United States
- PDYN United States
- Employees
- TLSI N/A
- PDYN N/A
- Industry
- TLSI Medical Specialities
- PDYN Wholesale Distributors
- Sector
- TLSI Health Care
- PDYN Industrials
- Exchange
- TLSI Nasdaq
- PDYN Nasdaq
- Market Cap
- TLSI 244.3M
- PDYN 271.4M
- IPO Year
- TLSI N/A
- PDYN N/A
- Fundamental
- Price
- TLSI $4.70
- PDYN $7.50
- Analyst Decision
- TLSI Strong Buy
- PDYN Hold
- Analyst Count
- TLSI 4
- PDYN 1
- Target Price
- TLSI $11.13
- PDYN $8.00
- AVG Volume (30 Days)
- TLSI 131.5K
- PDYN 2.0M
- Earning Date
- TLSI 11-13-2025
- PDYN 11-07-2025
- Dividend Yield
- TLSI N/A
- PDYN N/A
- EPS Growth
- TLSI N/A
- PDYN N/A
- EPS
- TLSI N/A
- PDYN N/A
- Revenue
- TLSI $35,990,000.00
- PDYN $4,357,000.00
- Revenue This Year
- TLSI $56.71
- PDYN N/A
- Revenue Next Year
- TLSI $52.25
- PDYN $44.25
- P/E Ratio
- TLSI N/A
- PDYN N/A
- Revenue Growth
- TLSI 45.50
- PDYN N/A
- 52 Week Low
- TLSI $3.42
- PDYN $1.69
- 52 Week High
- TLSI $5.88
- PDYN $14.95
- Technical
- Relative Strength Index (RSI)
- TLSI 45.51
- PDYN 38.69
- Support Level
- TLSI $4.87
- PDYN $7.80
- Resistance Level
- TLSI $5.18
- PDYN $8.60
- Average True Range (ATR)
- TLSI 0.23
- PDYN 0.69
- MACD
- TLSI -0.01
- PDYN -0.20
- Stochastic Oscillator
- TLSI 44.74
- PDYN 1.53
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About PDYN Palladyne AI Corp.
Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.